| Bioactivity | Val-Cit-PABC-DOX (compound 10109), an epsilon-poly-L-lysine-based drug conjugate, is an agent-linker conjugate for ADC by using a DNA topoisomerase I and topoisomerase II inhibitor, Doxorubicin (HY-15142), linked via the linker, Val-Cit-PABC[1]. |
| CAS | 1022094-34-3 |
| Formula | C46H56N6O16 |
| Molar Mass | 948.97 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Furao Zhang, et al. Epsilon-poly-l-lysine-based drug conjugate, intermediate thereof, and application thereof. WO2023078464A1. |
Val-Cit-PABC-DOX
CAS: 1022094-34-3 F: C46H56N6O16 W: 948.97
Val-Cit-PABC-DOX (compound 10109), an epsilon-poly-L-lysine-based drug conjugate, is an agent-linker conjugate for ADC b
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.